Tag Archives: regulations

How consumers can interact with state medical boards

How can consumers interact with state medical boards? – National Pain Report – by Geoff Sims – Oct 2019

Editor’s Note: When Dr. Thomas Kline tweeted last week that it’s time for chronic pain patients to “flood state medical boards with online complaints” about being cutoff w/ the CDC and “federal drug police invalid medical excuses, we asked Terri Lewis Ph.D. for an article that shows patients how they can do it and why it might be a good idea.

Many patients do not know where to turn when they have concerns about the competency or conduct of a doctor. State medical boards are government agencies, usually housed in state Departments of Health, that are empowered to investigate complaints about doctors and, when warranted, take action against them.   Continue reading

Indian industry in denial over drug-quality charges

Indian pharmaceutical industry in denial over drug-quality charges – STAT

Katherine Eban’s new book, “Bottle of Lies,” has focused a very intense spotlight on the mostly ignored transgressions of the Indian generic pharmaceutical industry in the processes they follow — or all too often don’t follow — to make quality products.

This industry, which has rarely been subjected to such rigorous journalistic scrutiny, has lashed back at Eban, attacking her integrity and her work.

The latest salvo comes from Kiran Mazumdar Shaw, who calls Eban’s exposé anecdotal, biased, unfair, and unbalanced, and accuses the author of playing up to the poor perceptions of the Indian pharmaceutical industry and the country.   Continue reading

The Opioid Crisis Is About More Than Corporate Greed

The Opioid Crisis Is About More Than Corporate Greed – By Zachary Siegel Jul 2019

Nearly every step of the pharmaceutical supply chain is implicated in the soaring death rate.

But the companies claim to have been acting legally and in compliance with federal regulators like the Drug Enforcement Administration (DEA).

Was it all, technically, legal?  

Of course, it was legal; pharmaceutical companies are enjoying their legal scheme of profiteering and wouldn’t do anything to endanger that privilege.
Continue reading

FDA seeking ‘right balance’ for opioid regulations

FDA seeking ‘right balance’ in regulating opioid prescriptions | BioPharma Dive By Rebecca Pifer Published July 10, 2018

Food and Drug Administration chief Scott Gottlieb reaffirmed in a statement Monday the agency’s commitment to finding the “right balance” between reducing the U.S. rate of opioid addiction and providing access to legitimate patients, for whom these medications can be lifesaving.

He had strong words for practitioners regarding their role in helping spur the opioid epidemic. “The roots of this crisis are embedded in the practice of medicine, and prescribing practices that were at times too cavalier,” Gottlieb said.

No, they are not. The “roots” of this crisis are the skyrocketing rates of addiction. And the problem is expanding much farther than just opioids, with use of and overdoses from drugs like meth and cocaine rising.  Continue reading